| T cell repertoire dynamics and oncolytic viral therapy |
2021-8-16 |
2021-9-30 |
|
| Reoviruses having modified sequences |
2020-2-13 |
2020-7-30 |
|
| Liquid viral formulations |
2019-11-05 |
2020-1-30 |
|
| Lyophilized viral formulations |
2018-8-17 |
2018-11-08 |
|
| Oncolytic viruses and increased cancer treatment regimens |
2014-11-12 |
2017-4-19 |
|
| Methods of treating taxane naïve subjects with primary tumors or with … |
2014-8-07 |
2015-2-12 |
|
| Viral purification methods |
2014-2-07 |
2019-1-01 |
2019-1-01 |
| Modulating interstitial pressure and tumor lysis virus delivery and … |
2013-12-03 |
2014-3-06 |
|
| Methods of purifying viruses using gel permeation chromatography |
2013-9-17 |
2017-5-29 |
|
| Virus clearance of neoplastic cells from mixed cellular compositions |
2013-5-28 |
2013-10-17 |
|
| Abrogating proinflammatory cytokine production during oncolytic reovirus … |
2013-5-21 |
2013-9-19 |
|
| Protecting modified viruses from neutralizing antibodies using the reovirus … |
2013-4-26 |
2013-11-16 |
|
| Reoviruses having modified sequences |
2013-3-22 |
2013-4-11 |
|
| Use of Ribozymes in the Detection of Adventitious Agents |
2012-9-27 |
2013-1-24 |
|
| Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus |
2012-9-24 |
2013-1-17 |
|
| Oncolytic viruses as phenotying agents for neoplasms |
2012-6-04 |
2013-3-24 |
|
| Use of ribozyme in detection of adventitious agent |
2012-3-29 |
2012-7-05 |
|
| Reovirus clearance of ras-mediated neoplastic cells from mixed cellular … |
2012-2-29 |
2013-8-20 |
2013-8-20 |
| Improved viral purification method |
2011-11-28 |
2012-3-01 |
|
| Methods for the treatment of cellular proliferative disorders |
2010-10-04 |
2010-12-17 |
|
| Use of adenovirus mutated in va gene for cancer treatment |
2010-6-01 |
2010-8-26 |
|
| Treatment regime for proliferative disorders |
2010-3-26 |
2011-6-29 |
|
| Mutant reoviruses and methods of making and using |
2010-2-24 |
2010-6-18 |
|
| Use of low dose local immune suppression to enhance oncolytic viral therapy |
2008-11-07 |
2009-1-16 |
|
| Use of local immune suppression to enhance oncolytic viral therapy |
2008-8-11 |
2008-10-03 |
|
| Virus clearance of neoplastic cells from mixed cellular composition |
2008-6-25 |
2008-11-27 |
|
| Reoviruses having modified sequences |
2008-3-11 |
2010-1-13 |
|
| Treatment with an oncolytic virus and an immunostimulant for in vivo … |
2008-1-16 |
2008-8-07 |
|
| Method of Extracting Virus from Cell Culture |
2007-8-24 |
2007-10-11 |
2007-10-11 |
| Method of extracting virus from cell culture |
2007-8-15 |
2007-11-15 |
|
| Method for reducing pain using oncolytic viruses |
2007-6-01 |
2008-4-03 |
|
| Use of local immune suppression to enhance oncolytic viral therapy |
2007-2-09 |
2009-11-25 |
|
| Method of producing infectious reovirus |
2006-8-30 |
2006-11-24 |
|
| Combination of transplantation and oncolytic virus treatment |
2005-3-10 |
2005-9-29 |
|
| Oncolytic viruses as phenotyping agents for neoplasms |
2004-12-07 |
2006-5-31 |
|
| Method of reducing pain using oncolytic viruses |
2004-10-20 |
2006-7-26 |
|
| Improved viral purification method |
2004-10-15 |
2006-7-26 |
|
| Sensitization of neoplastic cells to radiation therapy with oncolytic viruses |
2004-10-14 |
2005-12-18 |
|
| Use of adenoviruses in the va genes for cancer treatment |
2004-8-26 |
2006-7-26 |
|
| Use of ribozymes in the detection of adventitious agents |
2004-8-04 |
2010-12-30 |
|
| Oncolytic viruses for the treatment of neoplasms having activated PP2A or Rac |
2004-7-06 |
2005-1-27 |
|
| Combination of transplantation and oncolytic virus treatment |
2004-3-12 |
2005-9-12 |
|
| Reovirus for the treatment of ral-mediated cellular proliferative disorders |
2003-11-06 |
2007-1-16 |
2007-1-16 |
| Reovirus for the treatment of lymphoid malignancies |
2003-7-25 |
2005-1-25 |
|
| Oncolytic virus for purging cellular compositions of cells of lymphoid … |
2003-7-25 |
2005-1-25 |
|
| Oncolytic viruses for the treatment of neoplasms having activated pp2a or rac |
2003-7-07 |
2005-1-07 |
|
| Sensitization of neuplastic cells to radiation therapy with oncolytic viruses. |
2003-5-08 |
2006-2-22 |
|
| Method for reducing pain using oncolytic viruses |
2003-5-07 |
2008-7-16 |
|
| Use of adenoviruses mutated in the va genes for cancer treatment |
2003-3-25 |
2006-4-30 |
|
| Use of adenoviruses mutated in the VA genes for cancer treatment |
2003-3-25 |
2007-5-31 |
|
| Methods for the treatment of cellular proliferative disorders |
2003-3-14 |
2004-9-14 |
|
| Use of reovirus in combination with anti-anti-reovirus antibodies for the … |
2003-1-08 |
2010-12-30 |
|
| Reovirus for the treatment of ral-mediated cellular proliferative disorders |
2002-11-07 |
2013-1-22 |
2013-1-22 |
| Clearance of neoplastic cells from mixed cellular compositions using viruses. |
2002-10-29 |
2003-10-29 |
|
| Method of extracting virus from cell culture |
2002-3-15 |
2009-12-21 |
2009-12-21 |
| Method of extracting virus from cell culture |
2002-3-15 |
2009-9-11 |
2009-9-11 |
| Method of extracting virus from cell culture |
2002-3-11 |
2002-10-03 |
|
| Sensitization of chemotherapeutic agent resistant neoplastic cells with … |
2002-2-20 |
2009-9-01 |
2009-9-01 |
| Sensitization of chemotherapeutic agent resistant neoplastic cells with … |
2002-2-19 |
2003-2-27 |
|
| Method for optimally delivering virus to a solid tumor mass |
2001-11-15 |
2002-5-23 |
|
| Methods for the treatment of cellular proliferative disorders |
2001-10-26 |
2006-2-11 |
2006-2-11 |
| Methods for the treatment of cellular proliferative disorders |
2001-10-26 |
2002-7-25 |
|
| Uso de supresion inmunitaria local para mejorar el tratamiento viral oncolitico |
2008-8-11 |
2008-10-03 |
|